🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Namrata Parikh @rednephron A summary of vasculitis trials👇

Methylprednisolone Versus Plasma Exchange for Renal Vasculitis (MEPEX) trial showed improved kidney outcomes in those w/ severe kidney disease (SCr >5.7 who were treated with plasma exchange ca. 2007 #Nephpearls #NephJC #VisualAbstract by Madhuri Ramakrishnan jasn.asnjournals.org/content/jnephr…

Joel M. Topf, MD FACP Insert a creatinine of 8-10 here too.

El resumen visual: FELZARTAMAB en el Rechazo mediado por Anticuerpos #nephjc NEJM shahin mohammed Milagros Flores nephjc.com/news/felzartam…

T0c: 🏅Check out the crisp #NephJC summary from Kajaree Giri and Mdh Aziz 🔗nephjc.com/news/felzartam…

What an amazing work 💫💫

T3j 👉 New anti-CD38 drugs #NephJC Felzartamab leads the pack, with more in development. Awaiting further studies on its efficacy with more head to head trials with existing AMR treatments. Infographic by Kajaree Giri

T0f/❓ Is Felzartamab (a new anti-CD38 monoclonal antibody) effective for treating Antibody Mediated Rejection (AMR)? 👉Before marching on to the evidence, let’s have a small reflection #NephJC

🎉Calentando motores y trabajos aceptados Samantha Verdugo Alejandro Garcia-Rivera Omar Sánchez Vázquez 🎉 💡No olvides participar y recuerda todos los caminos nos llevan al #ISNWCN🇮🇳 All roads lead to World Congress of Nephrology Int Society of Nephrology 🌍

Kidney disease is a silent disease. Make kidney disease a priority!! Sign our petition theisn.org/in-action/advo…

🏆The Top Nephrology Stories of 2024 nephjc.com/news/2024/1/15… 🦋Join us for a #NephJC chat on BlueSky tonight!

Dear Nephrologists and Gastroenterologists-Please spare 5 mins for our survey on managing renal issues in cirrhosis. Your insights will help us to present the trends and gaps at #WCN2025 under ‘The Interconnected Kidney.’ Kindly share with fellow #Nephrologists & #Hepatologists.

Happening now Alejandro Garcia-Rivera is debating if AI can replace us in kidney care! #ISNWCN Join us in hall 301 😍👌

Infusión continua vs intermitente de carbapenémicos. Ensayos BLING III y MERCY. #BLINGIIITrial #MERCYTrial ¿Qué equipo son?

You know we love it. 🫘 A gift from my mentor Milagros Flores 🫶🏼 #flozinators

🖼️Check out the VA for tonight's #NephJC discussion on #Bluesky at 9pm EST by Dr. Divya Bajpai 🇮🇳 Join us for our second primary aldosterone discussion in "Aldo February" ♥️! nephjc.com/news/2025/2/24…

Y así, se concluye una semana más de detección de enfermedad renal, con la intención de poder intervenir y lograr un cambio en la vida de los pacientes de manera oportuna.

🤰 Hemodialysis in pregnancy VA by Alejandro Garcia-Rivera

With unshakable CONFIDENCE, finerenone and empagliflozin waltz into diabetic kidney disease - turning 'maybe someday' into 'why not today?' ✍️#NephJC summary by Sejal Lakhani, DO and Jeyakumar Meyyappan ⏰🦋Chat happening on July 8, 9 pm EST nephjc.com/news/confidenc…